Compliance Rate
Compliance Rate
48.0%
Compliant submissions
48
Incompliant submissions
52
Total trials
100
Your Clinical Trials
Showing 542200 of 542236 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 10/31/14
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 11/30/24
Due: 11/30/25
Phase: N/A
Priority: Normal
Start: 08/14/14
End: 01/25/26
Due: 01/25/27
Phase: N/A
Priority: Normal
Start: 12/11/23
End: 06/11/26
Due: 06/11/27
Phase: N/A
Priority: Normal
Start: 04/30/23
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 04/03/19
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 01/01/11
End: 08/31/18
Due: 08/31/19
Phase: N/A
Priority: Normal
Start: 04/01/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 12/31/21
Due: 12/31/22
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
Phase: N/A
Priority: Normal
Start: 01/15/25
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 06/01/18
End: 12/01/24
Due: 12/01/25
Phase: N/A
Priority: Normal
Start: 01/01/17
End: 02/15/19
Due: 02/15/20
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 07/31/30
Due: 07/31/31
Phase: N/A
Priority: Normal
Start: 09/26/14
End: 08/04/18
Due: 08/04/19
Phase: N/A
Priority: Normal
Start: 03/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/19/19
End: 12/19/38
Due: 12/19/39
Phase: N/A
Priority: Normal
Start: 06/01/18
End: 12/30/18
Due: 12/30/19
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 10/18/16
End: 07/27/23
Due: 07/27/24
Phase: N/A
Priority: Normal
Start: 04/30/21
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 01/31/16
Due: 01/31/17